Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)最新文献

{"title":"Journal of the American Pharmaceutical Association Guidelines for Authors","authors":"","doi":"10.1331/10865800360467141","DOIUrl":"10.1331/10865800360467141","url":null,"abstract":"","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"43 1","pages":"Pages 111-113"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1331/10865800360467141","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31657560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Zada Mary Cooper (1875-1961)","authors":"Dennis B. Worthen PhD (editor)","doi":"10.1331/10865800360467196","DOIUrl":"10.1331/10865800360467196","url":null,"abstract":"","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"43 1","pages":"Pages 124-126"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1331/10865800360467196","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31657565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Where is technology taking pharmacy? (Better yet, where is pharmacy taking technology?).","authors":"Brad Tice","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"43 1","pages":"7-9"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22244477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"State of CAM education in U.S. schools of pharmacy: results of a national survey.","authors":"Arjun P Dutta, Monika N Daftary, Patricia Ayuk Egba, Hyon Kang","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"43 1","pages":"81-3"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22245538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"New biotechnology approvals for 2002.","authors":"Peggy Piascik","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"43 1","pages":"116-7"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22245541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sesquicentennial Stepping Stone Summits--Summit Two: pharmacy technicians.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"43 1","pages":"84-92"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22245544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Proposed Ethical Framework for Prescription Drug Benefit Allocation Policy","authors":"J. Russell Teagarden MA (vice president),&nbsp;Norman Daniels PhD (professor),&nbsp;James E. Sabin MD (Professor)","doi":"10.1331/10865800360467079","DOIUrl":"10.1331/10865800360467079","url":null,"abstract":"<div><h3>Objectives:</h3><p>To present an ethical framework that could aid prescription drug benefit design and to propose that such a framework could be organized around a benefit allocation hierarchy.</p></div><div><h3>Summary:</h3><p>Four hierarchical levels of allocation are proposed, as follows: (1) drug categories and subcategories, (2) individual drugs within covered drug categories, (3) specific indications of covered drugs, and (4) special features of drug use, such as quantities covered for specific indications. Rationales for decision making should address the distinct ethical issues apparent at each level.</p></div><div><h3>Conclusion:</h3><p>Ethical issues associated with designing and managing a pharmacy benefit can be identified by using a hierarchical prescription drug allocation scheme. Articulating these issues is an important first step toward arriving at a fully developed framework that will serve to produce rationales acceptable to typical stakeholders in prescription drug benefits.</p></div>","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"43 1","pages":"Pages 69-74"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1331/10865800360467079","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31657553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"New Biotechnology Approvals for 2002","authors":"Peggy Piascik PhD (associate professor)","doi":"10.1331/10865800360467169","DOIUrl":"10.1331/10865800360467169","url":null,"abstract":"","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"43 1","pages":"Pages 116-117"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1331/10865800360467169","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31657562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Autopsy: Coaxing Secrets From the Dead","authors":"Jeannette Y. Wick RPh, MBA (senior clinical research pharmacist),&nbsp;Guido R. Zanni PhD","doi":"10.1331/10865800360467006","DOIUrl":"10.1331/10865800360467006","url":null,"abstract":"The word “autopsy” was derived from the Greek autopsia, meaning “to see with one's eyes.” Throughout most of history, autopsy findings were limited to what could be deduced from the evidence available to the naked eye. Today, x-ray and medical technology augment the pathologist's eyes, allowing more than just visual examination of bodies. Autopsy is the gold standard for ascertaining cause of death in American medicine, serving to confirm pathology, clinical diagnoses, and the appropriateness of pre-death treatments. Autopsy findings wind their way to practicing pharmacists via circuitous routes. Researchers and toxicologists use autopsy findings to monitor how drugs really work over the short and long terms. Regulators and legislators connect autopsy findings with police reports, medication error reports, and case reports to develop new labeling or implement stricter laws. Medical chemists use the same findings to seek new and better drugs. Language: en","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"43 1","pages":"Pages 18-23"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1331/10865800360467006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31657635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pain management content in curricula of U.S. schools of pharmacy.","authors":"Rubina M Singh,&nbsp;Susan L Wyant","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>To identify individuals in schools of pharmacy in the United States who are responsible for covering the topic of pain management in courses for doctor of pharmacy students and to describe how and at what depth pain management is covered in pharmacy school curricula.</p><p><strong>Design: </strong>One-time qualitative assessment.</p><p><strong>Setting: </strong>Schools of pharmacy in the United States. PARTICIPANTS Twenty-eight faculty members with the rank of professor, associate professor, or assistant professor who had been employed in their current positions for at least 2 years and who were directly involved in preparing and teaching didactic courses that address pain management.</p><p><strong>Intervention: </strong>In-depth telephone interviews.</p><p><strong>Main outcome measures: </strong>Qualitative responses to open-ended interview questions.</p><p><strong>Results: </strong>While pain management was included in the curricula of all 28 schools of pharmacy, it was generally covered in a fragmented way, usually as part of presentations on diseases with pain as a prominent feature (e.g., cancer pain addressed during oncology lectures) or as part of discussions of analgesics. Only two schools offered stand-alone courses in pain management, and both of those courses were electives that were taken by an average of 15 students per year. Three-fourths of respondents believed that pain was being given too little emphasis in their schools' curricula. Palliative care and the use of medications in the treatment of cancer pain was not presented in a standardized manner, and respondents were unsure of how the subject was covered in pharmacy law classes. Instruction about the diagnosis of pain, patient assessment, and physical examination was reported as \"minimal\" by most respondents. Respondents perceived a need for a single, complete reference and teaching resource that would address the entire spectrum of pain management as it applies to pharmacy.</p><p><strong>Conclusion: </strong>The topic of pain management is poorly presented and inadequately developed in the curricula of many U.S. schools of pharmacy.</p>","PeriodicalId":79444,"journal":{"name":"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)","volume":"43 1","pages":"34-40"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22244483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}